Abstract
Data suggest that more men than women are dying of coronavirus disease 2019 (COVID-19) worldwide, but it is unclear why. A biopsychosocial approach is critical for understanding the disproportionate death rate among men. Biological, psychological, behavioral, and social factors may put men at disproportionate risk of death. We propose a stepwise approach to clinical, public health, and policy interventions to reduce COVID-19-associated morbidity and mortality among men. We also review what health professionals and policy makers can do, and are doing, to address the unique COVID-19-associated needs of men.
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Betacoronavirus*
-
COVID-19
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / immunology
-
Coronavirus Infections / mortality*
-
Coronavirus Infections / psychology*
-
Female
-
Health Policy*
-
Health Promotion
-
Humans
-
Male
-
Pandemics
-
Patient Education as Topic / methods
-
Peptidyl-Dipeptidase A / blood
-
Peptidyl-Dipeptidase A / metabolism
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / mortality*
-
Pneumonia, Viral / psychology*
-
Preventive Medicine
-
Public Health
-
Risk Factors
-
SARS-CoV-2
-
Sex Factors
-
United States / epidemiology
Substances
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2